Indications for Blood Transfusions: Too Complex to Base on a Single Number?

Editorials3 July 2012Indications for Blood Transfusions: Too Complex to Base on a Single Number?FREEJean-Louis Vincent, MD, PhDJean-Louis Vincent, MD, PhDFrom Erasme University Hospital, Brussels, Belgium.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-156-12-201206190-00431 SectionsAboutVisual AbstractPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this issue, the AABB (formerly the American Association of Blood Banks) presents a clinical practice guideline for red blood cell transfusion (1). The guideline nicely reports the risks associated with transfusions, and I do not want to challenge the conclusions reached by this distinguished group of experts. Indeed, it would be difficult to argue with their statement that “On the basis of data from all the randomized trials, the panel found little evidence to support a liberal transfusion strategy.” Certainly, ample evidence supports the assertion that, in general, less may be better when it comes to blood transfusion.Yet, considering the supporting evidence and the questions the panel focused on, I do challenge the strict transfusion triggers provided by the panel. First, in developing the guidelines, the panel focused more on blood transfusion and its related problems than on the problems associated with anemia. In any decision to transfuse, one must weigh the risks and benefits associated with transfusion against those associated with anemia. Although blood transfusions have been associated with adverse outcomes, anemia is also associated with increased mortality rates (2–4). Second, the quality of blood has improved over the years. In particular, it is likely (although not definitely proven) that leukoreduction has helped decrease some of the harmful effects of blood transfusion (5). Observational studies in Europe have suggested that transfusion has become safer over time. For example, blood transfusion was an independent risk factor for mortality in the ABC (Anemia and Blood Transfusion in Critical Care) study conducted in 1999 (6) but not in the SOAP (Sepsis Occurrence in Acutely Ill Patients) study conducted several years later (7), although similar statistical techniques (including multivariable analyses and propensity scoring) were used in the 2 studies. Third and most important, the studies evaluating liberal versus conservative blood transfusion practices have usually addressed the simple question of number of transfusions, without taking into account particular characteristics of the patient populations, especially the presence of coronary artery disease (CAD) and patient age.Perhaps the most influential of these studies was that by Hébert and colleagues (8), in which patients were assigned to a restrictive (transfusion if hemoglobin level <7 g/dL) or more liberal (transfusion if hemoglobin level <10 g/dL) strategy. Patients in the restrictive group had similar 30-day mortality rates (and even lower mortality rates in the subgroup of patients with higher disease severity [Acute Physiology and Chronic Health Evaluation II {APACHE II} score ≤20] and in patients younger than 55 years). This well-performed, multicenter study serves as the strongest basis for the AABB's recommendation of a hemoglobin level of 7 g/dL as the threshold for transfusion. However, several limitations of the study warrant consideration. First, it was conducted more than 10 years ago and blood preservation techniques have improved since then. In particular, leukoreduction was not in practice when the study was done. Second, the investigators enrolled only a small fraction (838 of 6451, or 13%) of evaluated patients, and the study was stopped early due to slow enrollment. These factors raise questions about the generalizability of the observations. Reanalyzing the data some years later, Deans and colleagues (9) highlighted that 30-day mortality was lower in the restrictive group than in the liberal group in patients without CAD (16% vs. 25%) but was higher in the restrictive group among patients with CAD (26% vs. 21%; P = 0.03). The European SOAP group of investigators initiated but quickly aborted a study comparing hemoglobin thresholds of 7 versus 9 g/dL, because too many patients did not meet inclusion criteria and the enrollment rate was very slow. For example, clinicians were uncomfortable with the idea of assigning a young trauma patient after bleeding was controlled to the 9-g/dL group, or an elderly patient with CAD to the 7-g/dL group. The current AABB guidelines (1) consider the impact of CAD by providing a weak recommendation that the transfusion threshold should simply be increased from 7 g/dL to 8 g/dL for patients with preexisting cardiovascular disease.The specific AABB transfusion thresholds are provided to help standardize transfusion practice (1). I believe this approach is too simplistic; basing the decision to transfuse on hemoglobin levels alone is insufficient. Admittedly, using such typical symptoms of anemia as fatigue, tachycardia, and dyspnea (or mechanical ventilation) to help in such decisions is not ideal because they are common indicators of severity of illness. The use of a low Svo2 (venous oxygen saturation) may be helpful, but this has not been fully established (10). Transfusion decisions need to consider individual patient characteristics, including age and the presence of CAD, to estimate a specific patient's likelihood of benefit from transfusion. The decision to transfuse is too complex and important to be guided by a single number.Jean-Louis Vincent, MD, PhDErasme University HospitalBrussels 1070, BelgiumReferences1. Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, et al; Clinical Transfusion Medicine Committee of the AABB. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med. 2012;157:49-58. LinkGoogle Scholar2. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348:1055-60. [PMID: 8874456] CrossrefMedlineGoogle Scholar3. Mudumbai SC, Cronkite R, Hu KU, Wagner T, Hayashi K, Ozanne GM, et al. Association of admission hematocrit with 6-month and 1-year mortality in intensive care unit patients. Transfusion. 2011;51:2148-59. [PMID: 21985048] CrossrefMedlineGoogle Scholar4. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, et al. Anemia and blood transfusion in a surgical intensive care unit. Crit Care. 2010;14:R92. [PMID: 20497535] CrossrefMedlineGoogle Scholar5. Hébert PC, Fergusson D, Blajchman MA, Wells GA, Kmetic A, Coyle D, et al; Leukoreduction Study Investigators. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA. 2003;289:1941-9. [PMID: 12697796] CrossrefMedlineGoogle Scholar6. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, et al; ABC (Anemia and Blood Transfusion in Critical Care) Investigators. Anemia and blood transfusion in critically ill patients. JAMA. 2002;288:1499-507. [PMID: 12243637] CrossrefMedlineGoogle Scholar7. Vincent JL, Sakr Y, Sprung C, Harboe S, Damas P; Sepsis Occurrence in Acutely Ill Patients (SOAP) Investigators. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology. 2008;108:31-9. [PMID: 18156879] CrossrefMedlineGoogle Scholar8. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. [PMID: 9971864] CrossrefMedlineGoogle Scholar9. Deans KJ, Minneci PC, Suffredini AF, Danner RL, Hoffman WD, Ciu X, et al. Randomization in clinical trials of titrated therapies: unintended consequences of using fixed treatment protocols. Crit Care Med. 2007;35:1509-16. [PMID: 17440420] CrossrefMedlineGoogle Scholar10. Parsons EC, Hough CL, Seymour CW, Cooke CR, Rubenfeld GD, Watkins TR; the NHLBI ARDS Network. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care. 2011;15:R221. [PMID: 21936902] CrossrefMedlineGoogle Scholar Comments0 CommentsSign In to Submit A Comment Author, Article, and Disclosure InformationAuthors: Jean-Louis Vincent, MD, PhDAffiliations: From Erasme University Hospital, Brussels, Belgium.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M12-0692.Corresponding Author: Jean-Louis Vincent, MD, PhD, Department of Intensive Care, Erasme University Hospital, Université libre de Bruxelles, Brussels 1070, Belgium; e-mail, jlvincen@ulb.ac.be.This article was published at www.annals.org on 27 March 2012. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRed Blood Cell Transfusion Jeffrey L. Carson , Sunil V. Rao , and Louis M. Katz Red Blood Cell Transfusion Harvey G. Klein and Charles Natanson Metrics Cited byBlood Transfusion in Patients with Acute Traumatic Brain InjuryUsing arterial-venous oxygen difference to guide red blood cell transfusion strategyPhysiological and microvascular responses to hemoglobin concentration-targeted hemolytic anemia in ratsAnticoagulation and Transfusions Management in Veno-Venous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: Assessment of Factors Associated With Transfusion Requirements and MortalityHemoglobin trigger and approach to red blood cell transfusions during veno-venous extracorporeal membrane oxygenation: the international TRAIN-ECMO surveyPatient Blood ManagementDo trials that report a neutral or negative treatment effect improve the care of critically ill patients? NoUmbrales transfusionales y transfusión de hematíes enfocada a la microcirculaciónTransfusion thresholds and red blood cells transfusion focused on tissue oxygenationTransfusion Decision Making in Pediatric Critical Illness2016 proceedings of the National Heart, Lung, and Blood Institute's scientific priorities in pediatric transfusion medicineLiberal Versus Restrictive Transfusion Strategy in Critically Ill Oncologic PatientsSpecific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in ChildrenAnesthesia and Management of Intraoperative BleedingRestrictive Transfusion Strategy Does Not Affect Clinical Prognosis in Patients with Ectopic PregnancyAnemia management after acute brain injuryNavigating the Fine Line Between the Bad and Worse: The Issue Is Not the Number, and the Message Is Not “All or Nothing”Lower blood loss after unicompartmental than total knee arthroplastyNon-invasive monitoring of oxygen delivery in acutely ill patients: new frontiersShould red cell transfusion be individualized? YesA liberal strategy of red blood cell transfusion reduces cardiogenic shock in elderly patients undergoing cardiac surgeryWhich carries the biggest risk: Anaemia or blood transfusion?Response to Perner et al.: testing current practice is no mistakeIs it time to integrate patient blood management in ERAS guidelines?Anemia, Fatigue and AgingRed Blood Cell Transfusion Trigger in SepsisPost-operative management in transfusion-free medicine and surgery in the ICUEffects of red blood cell transfusion on hemodynamic parameters: a prospective study in intensive care unit patientsThe Transfusion of Red CellsWhat’s new in transfusion policies?Review article: Risks of anemia and related management strategies: can perioperative blood management improve patient safety?Blood transfusion in the perioperative periodRed Blood Cell TransfusionHarvey G. Klein, MD and Charles Natanson, MDRed Blood Cell TransfusionJeffrey L. Carson, MD, Sunil V. Rao, MD, and Louis M. Katz, MD 3 July 2012Volume 157, Issue 1Page: 71-72KeywordsAnemiaBloodBlood transfusionDeath ratesHemoglobinMortalityRed blood cellsRisk managementSoapsTreatment guidelines ePublished: 3 July 2012 Issue Published: 3 July 2012 Copyright & PermissionsCopyright © 2012 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...